• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIN Hui,GE Maoxu.Study on the Mechanism of Tiaoshen Gongjian Decoction Intervening Liver Fibrosis Based on Network Pharmacology[J].Journal Of Pharmaceutical Research,2022,41(7):435-441[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2540times   Download 2881次 QR Code for this article
Scan with your phone!
基于网络药理学探讨调神攻坚汤治疗肝纤维化的作用机制
林慧,葛茂旭
Font:Larger+|Default|Smaller-
(山东大学齐鲁医院,山东 济南 250012)
摘要:
目的 基于网络药理学研究方法探讨调神攻坚汤治疗肝纤维化的作用机制。方法 检索 TCMSP 和BATMAN-TCM数据库得到调神攻坚汤的有效活性成分及其相关作用靶点;并与检索OMIM和Genecards数据库得到的肝纤维化疾病作用靶点利用R语言筛选共同靶点;通过STRING数据库构建靶点间的蛋白互作PPI网络,随后利用Metascape平台进行GO功能和KEGG通路富集分析;利用 Cytoscape 3.7.2软件构建“中药-活性成分-疾病”靶点网络图,并经Cytohubba插件的MCC算法筛选出核心蛋白;再将其导入Genecards数据库中获得亚细胞分布。结果 通过筛选共计获得调神攻坚汤有效活性成分166个,作用靶点596个;经匹配后此方剂治疗肝纤维化的潜在靶点为193个;其中核心包括FN1、MMP2、TNF、IL-6、STAT3、CTNNB1等;GO以及KEGG分析显示调神攻坚汤可能通过调控炎症反应、脂质代谢、细胞凋亡等生物学过程治疗肝纤维化,并且涉及HIF-1、Foxo、PPAR等细胞信号转导通路。结论 通过网络药理学方法初步验证调神攻坚汤治疗肝纤维化是一个“多组分-多靶点-多通路”的过程,并预测其潜在作用机制,为后续临床及基础研究提供理论依据。
关键词:  网络药理学  调神攻坚汤  肝纤维化  作用机制  信号通路
DOI:10.13506/j.cnki.jpr.2022.07.003
基金项目:山东省自然科学基金青年基金项目(No.ZR2021QH204)
Study on the Mechanism of Tiaoshen Gongjian Decoction Intervening Liver Fibrosis Based on Network Pharmacology
LIN Hui,GE Maoxu
(Qilu Hospital of Shandong University,Jinan 250012,China)
Abstract:
Objective Study on the mechanism of Tiaoshen Gongjian Decoction intervening liver fibrosis based on network pharmacology.Methods The active ingredients and targets of Tiaoshen Gongjian Decoction were searched through TCMSP and BATMAN-TCM database; which were intersected with the therapeutic targets of liver fibrosis obtained from OMIM and Genecards database; protein-protein interaction (PPI) network of the above intersected genes was constructed through STRING database, GO ontology and KEGG pathway analyses were carried out by Metascape platform; Cytoscape 3.7.2 software was applied to construct a visual regulatory network map of " Chinese medicinal formulae - active components - disease", and the core proteins were screened out by MCC algorithm of Cytohubba and subsequently imported into Genecards database to acquire their subcellular distributions.Results A total of 166 active ingredients and 596 targets of Tiaoshen Jiejian decoction were obtained. After matching to the therapeutic targets of liver fibrosis, 193 potential targets were identified. The core proteins mainly include FN1, MMP2, TNF, IL-6, STAT3, CTNNB1, etc. GO and KEGG analysis showed that the therapeutic effects of this decoction in treating liver fibrosis might concentrate on regulating inflammatory response, lipid metabolism, apoptosis and other biological processes, and involve in HIF-1, FOXO, PPAR and other signaling pathways.Conclusion It was preliminarily verified that Tiaoshen Xiaojian decoction is a "multi-component, multi-target and multi-pathway" process in the treatment of liver fibrosis through network pharmacology, which potential mechanisms was predicted, providing theoretical basis for subsequent clinical and basic research.
Key words:  Network pharmacology  Tiaoshen Gongjian Decoction  Liver fibrosis  Mechanism of action  Signaling pathway
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.